ArticleGastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association2026
Clinicopathological characterization of extremely low-grade fundic gland tumors: a study of 11 of a variant of oxyntic gland adenomas.
Article in Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundGastric adenocarcinoma of the fundic gland type (GA-FG) is a well-characterized entity showing differentiation toward oxyntic gland cells. However, extremely low-grade lesions that do not meet the established diagnostic criteria for GA-FG are increasingly encountered in clinical practice. We aimed to characterize these lesions, which we termed a variant of oxyntic gland adenomas (OGAs).
methodsWe retrospectively reviewed 11 lesions in 10 patients with OGAs identified between 2018 and 2025. All lesions were managed via endoscopic surveillance. We evaluated the clinicopathological and endoscopic features of these lesions and performed immunohistochemical staining for MUC6, pepsinogen I, H⁺/K⁺-ATPase (proton pump), and cyclin D1.
resultsAll lesions were flat, whitish, and located in the upper stomach, notably lacking subepithelial tumor-like elevations. Magnifying endoscopy with narrow-band imaging revealed minimal structural changes on the surface. Histologically, the tumors showed well-circumscribed proliferation in the deep fundic mucosa, consisting of chief cell-like cells with minimal architectural atypia and an extremely low nuclear-to-cytoplasmic ratio. Although all lesions showed diffuse positivity for MUC6 and pepsinogen I, cyclin D1 expression was absent. No lesions showed progression or structural transformation during the follow-up period (range, 6-84 months).
conclusionsThese lesions represent a distinct clinicopathological entity characterized by minimal cytological atypia and lack of surface mucosal changes and cyclin D1 expression. Our findings suggest that these lesions are a variant of OGAs and behave as benign mimics of GA-FG. Recognizing this extremely low-grade variant is crucial to avoid overdiagnosis and unnecessary aggressive interventions.
Indexed as
Identifiers
42734684What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.